Impact of Physical Activity on Cardiovascular Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease.
We investigated whether accelerometer-assessed moderate-to-vigorous physical activity (MVPA) is associated with cardiovascular mortality among individuals with metabolic dysfunction-associated steatotic liver disease (MASLD) in the United States. Higher MVPA is nonlinearly associated with cardiovascular mortality in individuals with MASLD.
We investigated whether accelerometer-assessed moderate-to-vigorous physical activity (MVPA) is associated with cardiovascular mortality among individuals with metabolic dysfunction-associated steatotic liver disease (MASLD) in the United States. Higher MVPA is nonlinearly associated with cardiovascular mortality in individuals with MASLD.
What the study was
- Study design
- Observational or experimental study
- Population
- Human participants; details are provided in the abstract.
- Category
- Public Health
- Maturity
- Validated
- Journal
- Journal of gastroenterology and hepatology
Why it surfaced
Retained as a 8/10 high-priority candidate for Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk; PubMed metadata and abstract were assessed conservatively.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.